Pfizer Shares Are Trading Higher After the Company Reported Better-than-expected Q2 Financial Results
辉瑞股票在公司公布Q2财报超预期表现后上涨。
Pfizer Q2 2024 Adj. EPS $0.60 Beats $0.46 Estimate, Sales $13.283B Beat $13.024B Estimate
辉瑞2024年Q2调整后EPS为0.60美元，超出0.46美元的预期，销售额132.83亿美元超过130.24亿美元的预期
Pfizer Expects 2024 Sales Of $59.5B-$62.5B Compared To Prior Guidance Of $58.5B-$61.5B And Consensus Of $60.668B
辉瑞预计2024年销售额为595亿美元。相比之前的指导585亿美元和60.668亿美元的共识，这是625亿美元。